NANOCHON

Nanochon+color+logo+2018
Today, there is a solid clinical standard for treating joint disease: the total joint replacement. Yet, while the surgical devices and techniques used to implant them have been largely perfected, today’s standard replacement joints don’t last forever. The limited lifespan of common replacement joints limits their use to patients aged 55 or older. This leaves patients between ages 18 and 55 suffering from cartilage damage, traumatic injury, or early stage cartilage loss with limited treatment options.  Our company, Nanochon, is developing an implant that is designed to not only replace lost and damaged cartilage, but also to encourage new tissue growth. Using 3-D printing and novel material, the Nanochon implant is a sturdy medical advancement that is both an orthopedic load bearing implant as well a tissue growth scaffold. The Nanochon implant has the potential to deliver  faster and more successful recoveries for patients, while reducing costs to health providers, payers, and patients. Nanochon’s aim is to set a new clinical standard for cartilage restoration. 
On demand solutions for treating joint injury.

Profile Description

 

Nanochon, LLC, was founded in 2016 by Dr.s Ben Holmes and Nathan Castro, Ph.D. Both studied under Dr. Grace Zhang in the Bioengineering Laboratory for Nanomedicine and Tissue Engineering at the George Washington University.

Research and innovation are the core of Nanochon’s work. Dr. Holmes has recently completed a small animal study with the Chief of Orthopedic Surgery and Sports Medicine at Children’s National Medical Center and research faculty within the Sheikh Zayed Institute for Pediatric Surgical Innovation. Dr. Castro is also currently serving as a postdoctoral fellow In Dietmar Hutmacher’s world renowned 3-D printing lab at Queensland University of Technology.

In 2017 Nanochon received a Phase I SBIR from the National Science Foundation. The team has executed a manufacturing feasibility study with Materialise, a leader in 3D printed implants, and a proof of concept in a large animal model with CARE Research (Ft Collins CO).

Leave a Comment

Time limit is exhausted. Please reload the CAPTCHA.

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • PHPSESSID
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec_
  • wp-settings-
  • wp-settings-time-

Decline all Services
Accept all Services

This information will not be shared with third parties